Highlights Gemina Laboratories Ltd.

Equities

GLAB

CA3686501071

Market Closed - Canadian Securities Exchange Other stock markets 20:33:00 31/05/2024 BST			5-day change	1st Jan Change
0.45 ^CAD	-.--%		-.--%	-16.67%

04-02	Gemina Laboratories Sign First Strategic License Agreement	CI
03-18	Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gemina Laboratories Sign First Strategic License Agreement	04-02	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	12-29	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23	CI
Gemina Laboratories Ltd. Laboratories and ReadyGo Diagnostics Limited Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva	05/06/23	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	01/06/23	CI
Gemina Laboratories Ltd. Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement	17/05/23	CI
Gemina Laboratories Ltd. Completes Influenza A/B Diagnostic Test Prototype	06/01/23	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	29/12/22	CI
Gemina Laboratories Ltd. Announces Research Collaboration on Next Generation Biosensors	19/12/22	CI
Gemina Laboratories Ltd. acquired 19% stake in Rapivd Limited for £0.52 million.	06/12/22	CI
Gemina Laboratories Ltd. Enters into Licence and Manufacturing Agreements with International Point of Care, Inc	06/10/22	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	28/09/22	CI
Gemina Laboratories Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2022	28/06/22	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2022	31/05/22	CI
Gemina Laboratories Ltd. Completes Successful Human Clinical Performance Evaluation on Legio XTM COVID-19 Rapid Antigen Test	05/05/22	CI
Gemina Laboratories Ltd. Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test	28/04/22	CI
Gemina Laboratories Ltd. Provides Technical Development Update for Initial Diagnostic Test	31/03/22	CI
Gemina Laboratories Ltd. Announces Formation of UK Subsidiary, Gemina Laboratories (UK) Limited	23/02/22	CI
Gemina Laboratories Ltd. Announces Completion of Significant Development Step for Its SARS-COV-2 Rapid Test	03/02/22	CI
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	28/12/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Gemina Laboratories Ltd.

Equities

GLAB

CA3686501071

Highlights

Filters